Mannkind (MNKD) Capital Expenditures Growth (5y) (2015 - 2026)
Mannkind (MNKD) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mannkind |
1.21 Bn |
1.08 Bn |
82.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-22.84% |
| Dec 31, 2025 |
-19.28% |
| Sep 30, 2025 |
-175.08% |
| Jun 30, 2025 |
33.04% |
| Mar 31, 2025 |
59.47% |
| Dec 31, 2024 |
28.29% |
| Sep 30, 2024 |
-46.00% |
| Jun 30, 2024 |
48.11% |
| Mar 31, 2024 |
44.02% |
| Mar 31, 2021 |
-3.13% |
| Dec 31, 2020 |
9.48% |
| Sep 30, 2020 |
-68.21% |
| Jun 30, 2020 |
-43.20% |
| Mar 31, 2020 |
-62.30% |
| Dec 31, 2019 |
-13.80% |
| Sep 30, 2019 |
-15.57% |
| Jun 30, 2019 |
-42.46% |
| Mar 31, 2019 |
-28.19% |
| Mar 31, 2016 |
-10.51% |
| Dec 31, 2015 |
-39.61% |
